The heterogeneity of systemic inflammation in bronchiectasis

Respir Med. 2017 Jun;127:33-39. doi: 10.1016/j.rmed.2017.04.009. Epub 2017 Apr 17.


Background: Systemic inflammation in bronchiectasis is poorly studied in relation to aetiology and severity. We hypothesized that molecular patterns of inflammation may define particular aetiology and severity groups in bronchiectasis.

Method: We assayed blood concentrations of 31 proteins from 90 bronchiectasis patients (derivation cohort) and conducted PCA to examine relationships between these markers, disease aetiology and severity. Key results were validated in two separate cohorts of 97 and 79 patients from other centres.

Results: There was significant heterogeneity in protein concentrations across the derivation population. Increasing severity of bronchiectasis (BSI) was associated with increasing fibrinogen (rho = 0.34, p = 0.001 -validated in a second cohort), and higher fibrinogen was associated with worse lung function, Pseudomonas colonisation and impaired health-status. There were generally similar patterns of inflammation in patients with idiopathic and post-infectious disease. However, patients with primary immunodeficiency had exaggerated IL-17 responses, validated in a second cohort (n = 79, immunodeficient 12.82 pg/ml versus idiopathic/post-infectious 4.95 pg/ml, p = 0.001), and thus IL-17 discriminated primary immunodeficiency from other aetiologies (AUC 0.769 (95%CI 0.661-0.877)).

Conclusion: Bronchiectasis is associated with heterogeneity of systemic inflammatory proteins not adequately explained by differences in disease aetiology or severity. More severe disease is associated with enhanced acute-phase responses. Plasma fibrinogen was associated with bronchiectasis severity in two cohorts, Pseudomonas colonisation and health status, and offers potential as a useful biomarker.

Keywords: Acute-phase reaction; Bronchiectasis; Fibrinogen; Inflammation; Interleukin-17.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Reaction / metabolism
  • Aged
  • Biomarkers / blood*
  • Bronchiectasis / blood*
  • Bronchiectasis / diagnostic imaging
  • Bronchiectasis / physiopathology
  • Cohort Studies
  • Female
  • Fibrinogen / metabolism*
  • Health Status
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / immunology
  • Inflammation / blood*
  • Interleukin-17 / metabolism*
  • Male
  • Middle Aged
  • Pseudomonas / growth & development
  • Respiratory Function Tests / methods
  • Severity of Illness Index
  • Tomography, X-Ray Computed / methods


  • Biomarkers
  • IL17A protein, human
  • Interleukin-17
  • Fibrinogen